Further to this discussion, shareholders have just received a mail from Beasley, which is comforting me to go with him, as I was (mildly) suggesting in my previous post (Post #: 31240765). Mutton credited himself for successes that do not belong to him: high end of year share price due to the market more than to him, licences and partnerships initiated under Beasley and completed under him.
I still don't like the way he kicked out Andrew Beehag and how he increased the number of shares so he and the new board would be in first line to grab more of the juicy market through indirect interest.
I believe Beasley, with all his imperfections, is way cleaner than Mutton (who I understand has only a political and juridic experience). I will follow him.
I quote Beasley's letter:
"I have received support from many major shareholders including the two largest shareholders:
Jason Colquhoun, the corporate representative of the Company’s largest shareholder and vendor of THC’s Hydroponics Division:
“As representative of the Company’s largest shareholder, I support the resolutions proposed by Alan Beasley for the March 15 meeting. I believe that at this time it is proper for the Company to make changes at the board of directors level and I am behind Alan Beasley in making those changes.”
and recently appointed director and corporate representative of the second largest shareholder, Mr Steven Xu:
“Since being appointed a director, I have had the opportunity to consider the many aspects of the Company and have formed the view that a new board is appropriate.
“I strongly urge shareholders to support all the resolutions to be put to the meeting of March 15 as proposed by Alan Beasley.”
My purpose for calling the meeting, is to have shareholders confirm a Board of Directors who will:
- Act in the best interest of shareholders;
- Apply good corporate governance practices;
- Act in a transparent, communicative, and cooperative manner;
- Work in a team environment;
- Disclose matters which should be disclosed to shareholders and the market;
- Apply stringent fiscal disciple to expenditure of shareholder funds
Together with Steven Xu and the 2 new directors, it is my intention to continue to build on the successes initiated by the Company under my former Chairmanship, including:
- the awarding of 2 Medicinal Cannabis licences to Canndeo
- agreement with Endoca for importation of product
- partnership with BOL Pharma to initiate Clinical Trials in Australia.
We will also assess the veracity of new initiatives and implement them as appropriate where they conform with Australian law. It is also our intention to engage an executive search firm to conduct a search for an independent, well qualified, highly experienced and well-known Chairman."
(20min delay)